author_facet Vani, Kodela
Sompuram, Seshi R.
Schaedle, Anika K.
Balasubramanian, Anuradha
Bogen, Steven A.
Vani, Kodela
Sompuram, Seshi R.
Schaedle, Anika K.
Balasubramanian, Anuradha
Bogen, Steven A.
author Vani, Kodela
Sompuram, Seshi R.
Schaedle, Anika K.
Balasubramanian, Anuradha
Bogen, Steven A.
spellingShingle Vani, Kodela
Sompuram, Seshi R.
Schaedle, Anika K.
Balasubramanian, Anuradha
Bogen, Steven A.
Journal of Histochemistry & Cytochemistry
Analytic Response Curves of Clinical Breast Cancer IHC Tests
Histology
Anatomy
author_sort vani, kodela
spelling Vani, Kodela Sompuram, Seshi R. Schaedle, Anika K. Balasubramanian, Anuradha Bogen, Steven A. 0022-1554 1551-5044 SAGE Publications Histology Anatomy http://dx.doi.org/10.1369/0022155417694869 <jats:p> An important limitation in the field of immunohistochemistry (IHC) is the inability to correlate stain intensity with specific analyte concentrations. Clinical immunohistochemical tests are not described in terms of analytic response curves, namely, the analyte concentrations in a tissue sample at which an immunohistochemical stain (1) is first visible, (2) increases in proportion to the analyte concentration, and (3) ultimately approaches a maximum color intensity. Using a new immunostaining tool ( IHControls), we measured the analytic response curves of the major clinical immunohistochemical tests for human epidermal growth factor receptor type II (HER-2), estrogen receptor (ER), and progesterone receptor (PR). The IHControls comprise the analytes HER-2, ER, and PR at approximately log concentration intervals across the range of biological expression, from 100 to 1,000,000 molecules per test microbead. We stained IHControls of various concentrations using instruments, reagents, and protocols from three major IHC vendors. Stain intensity at each analyte concentration was measured, thereby generating an analytic response curve. We learned that for HER-2 and PR, there is significant variability in test results between clinical kits for samples with analyte concentrations of approximately 10<jats:sup>4</jats:sup> molecules/microbead. We propose that the characterization of immunostains is an important step toward standardization. </jats:p> Analytic Response Curves of Clinical Breast Cancer IHC Tests Journal of Histochemistry & Cytochemistry
doi_str_mv 10.1369/0022155417694869
facet_avail Online
Free
finc_class_facet Biologie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTM2OS8wMDIyMTU1NDE3Njk0ODY5
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTM2OS8wMDIyMTU1NDE3Njk0ODY5
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint SAGE Publications, 2017
imprint_str_mv SAGE Publications, 2017
issn 1551-5044
0022-1554
issn_str_mv 1551-5044
0022-1554
language English
mega_collection SAGE Publications (CrossRef)
match_str vani2017analyticresponsecurvesofclinicalbreastcancerihctests
publishDateSort 2017
publisher SAGE Publications
recordtype ai
record_format ai
series Journal of Histochemistry & Cytochemistry
source_id 49
title Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_unstemmed Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_full Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_fullStr Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_full_unstemmed Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_short Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_sort analytic response curves of clinical breast cancer ihc tests
topic Histology
Anatomy
url http://dx.doi.org/10.1369/0022155417694869
publishDate 2017
physical 273-283
description <jats:p> An important limitation in the field of immunohistochemistry (IHC) is the inability to correlate stain intensity with specific analyte concentrations. Clinical immunohistochemical tests are not described in terms of analytic response curves, namely, the analyte concentrations in a tissue sample at which an immunohistochemical stain (1) is first visible, (2) increases in proportion to the analyte concentration, and (3) ultimately approaches a maximum color intensity. Using a new immunostaining tool ( IHControls), we measured the analytic response curves of the major clinical immunohistochemical tests for human epidermal growth factor receptor type II (HER-2), estrogen receptor (ER), and progesterone receptor (PR). The IHControls comprise the analytes HER-2, ER, and PR at approximately log concentration intervals across the range of biological expression, from 100 to 1,000,000 molecules per test microbead. We stained IHControls of various concentrations using instruments, reagents, and protocols from three major IHC vendors. Stain intensity at each analyte concentration was measured, thereby generating an analytic response curve. We learned that for HER-2 and PR, there is significant variability in test results between clinical kits for samples with analyte concentrations of approximately 10<jats:sup>4</jats:sup> molecules/microbead. We propose that the characterization of immunostains is an important step toward standardization. </jats:p>
container_issue 5
container_start_page 273
container_title Journal of Histochemistry & Cytochemistry
container_volume 65
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792334382066827264
geogr_code not assigned
last_indexed 2024-03-01T14:27:45.803Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Analytic+Response+Curves+of+Clinical+Breast+Cancer+IHC+Tests&rft.date=2017-05-01&genre=article&issn=1551-5044&volume=65&issue=5&spage=273&epage=283&pages=273-283&jtitle=Journal+of+Histochemistry+%26+Cytochemistry&atitle=Analytic+Response+Curves+of+Clinical+Breast+Cancer+IHC+Tests&aulast=Bogen&aufirst=Steven+A.&rft_id=info%3Adoi%2F10.1369%2F0022155417694869&rft.language%5B0%5D=eng
SOLR
_version_ 1792334382066827264
author Vani, Kodela, Sompuram, Seshi R., Schaedle, Anika K., Balasubramanian, Anuradha, Bogen, Steven A.
author_facet Vani, Kodela, Sompuram, Seshi R., Schaedle, Anika K., Balasubramanian, Anuradha, Bogen, Steven A., Vani, Kodela, Sompuram, Seshi R., Schaedle, Anika K., Balasubramanian, Anuradha, Bogen, Steven A.
author_sort vani, kodela
container_issue 5
container_start_page 273
container_title Journal of Histochemistry & Cytochemistry
container_volume 65
description <jats:p> An important limitation in the field of immunohistochemistry (IHC) is the inability to correlate stain intensity with specific analyte concentrations. Clinical immunohistochemical tests are not described in terms of analytic response curves, namely, the analyte concentrations in a tissue sample at which an immunohistochemical stain (1) is first visible, (2) increases in proportion to the analyte concentration, and (3) ultimately approaches a maximum color intensity. Using a new immunostaining tool ( IHControls), we measured the analytic response curves of the major clinical immunohistochemical tests for human epidermal growth factor receptor type II (HER-2), estrogen receptor (ER), and progesterone receptor (PR). The IHControls comprise the analytes HER-2, ER, and PR at approximately log concentration intervals across the range of biological expression, from 100 to 1,000,000 molecules per test microbead. We stained IHControls of various concentrations using instruments, reagents, and protocols from three major IHC vendors. Stain intensity at each analyte concentration was measured, thereby generating an analytic response curve. We learned that for HER-2 and PR, there is significant variability in test results between clinical kits for samples with analyte concentrations of approximately 10<jats:sup>4</jats:sup> molecules/microbead. We propose that the characterization of immunostains is an important step toward standardization. </jats:p>
doi_str_mv 10.1369/0022155417694869
facet_avail Online, Free
finc_class_facet Biologie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTM2OS8wMDIyMTU1NDE3Njk0ODY5
imprint SAGE Publications, 2017
imprint_str_mv SAGE Publications, 2017
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1551-5044, 0022-1554
issn_str_mv 1551-5044, 0022-1554
language English
last_indexed 2024-03-01T14:27:45.803Z
match_str vani2017analyticresponsecurvesofclinicalbreastcancerihctests
mega_collection SAGE Publications (CrossRef)
physical 273-283
publishDate 2017
publishDateSort 2017
publisher SAGE Publications
record_format ai
recordtype ai
series Journal of Histochemistry & Cytochemistry
source_id 49
spelling Vani, Kodela Sompuram, Seshi R. Schaedle, Anika K. Balasubramanian, Anuradha Bogen, Steven A. 0022-1554 1551-5044 SAGE Publications Histology Anatomy http://dx.doi.org/10.1369/0022155417694869 <jats:p> An important limitation in the field of immunohistochemistry (IHC) is the inability to correlate stain intensity with specific analyte concentrations. Clinical immunohistochemical tests are not described in terms of analytic response curves, namely, the analyte concentrations in a tissue sample at which an immunohistochemical stain (1) is first visible, (2) increases in proportion to the analyte concentration, and (3) ultimately approaches a maximum color intensity. Using a new immunostaining tool ( IHControls), we measured the analytic response curves of the major clinical immunohistochemical tests for human epidermal growth factor receptor type II (HER-2), estrogen receptor (ER), and progesterone receptor (PR). The IHControls comprise the analytes HER-2, ER, and PR at approximately log concentration intervals across the range of biological expression, from 100 to 1,000,000 molecules per test microbead. We stained IHControls of various concentrations using instruments, reagents, and protocols from three major IHC vendors. Stain intensity at each analyte concentration was measured, thereby generating an analytic response curve. We learned that for HER-2 and PR, there is significant variability in test results between clinical kits for samples with analyte concentrations of approximately 10<jats:sup>4</jats:sup> molecules/microbead. We propose that the characterization of immunostains is an important step toward standardization. </jats:p> Analytic Response Curves of Clinical Breast Cancer IHC Tests Journal of Histochemistry & Cytochemistry
spellingShingle Vani, Kodela, Sompuram, Seshi R., Schaedle, Anika K., Balasubramanian, Anuradha, Bogen, Steven A., Journal of Histochemistry & Cytochemistry, Analytic Response Curves of Clinical Breast Cancer IHC Tests, Histology, Anatomy
title Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_full Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_fullStr Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_full_unstemmed Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_short Analytic Response Curves of Clinical Breast Cancer IHC Tests
title_sort analytic response curves of clinical breast cancer ihc tests
title_unstemmed Analytic Response Curves of Clinical Breast Cancer IHC Tests
topic Histology, Anatomy
url http://dx.doi.org/10.1369/0022155417694869